Fed. Circ. Urged To Upend Actavis' $12M Legal Fee Deduction
By Anna Scott Farrell · March 21, 2023, 1:56 PM EDT
The Federal Circuit should reverse a decision allowing drugmaker Actavis to deduct as regular business expenses $12 million it spent fighting lawsuits as it tried to secure approval to sell generic...
To view the full article, register now.